GE HealthCare Technologies Inc’s recent filing unveils that its Chief Accounting Officer Newcomb George A. unloaded Company’s shares for reported $0.19 million on Feb 18 ’25. In the deal valued at $92.54 per share,2,000 shares were sold. As a result of this transaction, Newcomb George A. now holds 7,462 shares worth roughly $0.63 million.
Then, Rott Roland sold 3,577 shares, generating $309,339 in total proceeds. Upon selling the shares at $86.48, the CEO, Imaging now owns 24,298 shares.
Before that, Roland Rott bought 3,577 shares. GE HealthCare Technologies Inc shares valued at $309,330 were divested by the Officer at a price of $86.48 per share.
Jefferies upgraded its GE HealthCare Technologies Inc [GEHC] rating to a Buy from a a Hold in a research note published on January 08, 2025; the price target was increased to $103 from $95. A number of analysts have revised their coverage, including UBS’s analysts, who decreased its forecast for the stock in late September from “a Neutral” to “a Sell”. BTIG Research also remained covering GEHC and has increased its forecast on September 18, 2024 with a “Buy” recommendation from previously “Neutral” rating. JP Morgan started covering the stock on September 09, 2024. It rated GEHC as “a Neutral”.
Price Performance Review of GEHC
On Tuesday, GE HealthCare Technologies Inc [NASDAQ:GEHC] saw its stock fall -2.48% to $84.31. Over the last five days, the stock has lost -7.16%. GE HealthCare Technologies Inc shares have risen nearly 7.84% since the year began. Nevertheless, the stocks have fallen -7.64% over the past one year. While a 52-week high of $94.80 was reached on 02/13/25, a 52-week low of $74.51 was recorded on 01/02/25. SMA at 50 days reached $85.84, while 200 days put it at $84.15.
Levels Of Support And Resistance For GEHC Stock
The 24-hour chart illustrates a support level at 82.47, which if violated will result in even more drops to 80.64. On the upside, there is a resistance level at 86.38. A further resistance level may holdings at 88.46. The Relative Strength Index (RSI) on the 14-day chart is 36.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.77%. Stochastics %K at 14.45% indicates the stock is a buying.
The most recent change occurred on August 06, 2024 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $100 price target.
